1. Adelaide Research & Scholarship

Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 11 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Management of hot flashes in patients who have breast cancer with Venlafaxine and Clonidine: a randomized, double-blind, placebo-controlled trialBoekhout, A.; Vincent, A.; Dalesio, O.; van den Bosch, J.; Foekema-Tons, J.; Adriaansz, S.; Sprangers, S.; Nuijen, B.; Beijnen, J.; Schellens, J.
2011Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancerDeenen, M.; Tol, J.; Burylo, A.; Doodeman, V.; de Boer, A.; Vincent, A.; Guchelaar, H.; Smits, P.; Beijnen, J.; Punt, C.; Schellens, J.; Cats, A.
2011Efficacy of α-lactalbumin and milk protein on weight loss and body composition during energy restrictionSoenen, S.; Hochstenbach-Waelen, A.; Westerterp-Plantenga, M.
2011Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high Vancomycin minimum inhibitory concentrationsHolmes, N.; Turnidge, J.; Munckhof, W.; Robinson, J.; Korman, T.; O'Sullivan, M.; Anderson, T.; Roberts, S.; Gao, W.; Christiansen, K.; Coombs, G.; Johnson, P.; Howden, B.
2011Anterior 180-degree partial fundoplication: A 16-year experience with 548 patientsChen, Z.; Thompson, S.; Jamieson, G.; Devitt, P.; Game, P.; Watson, D.
2011Composite grafts in eyelid reconstruction: The complications and outcomesCannon, P.; Madge, S.; Kakizaki, H.; Selva-Nayagam, D.
2011Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancerPrice, T.; Hardingham, J.; Lee, C.; Weickhardt, A.; Townsend, A.; Wrin, J.; Chua, A.; Shivasami, A.; Cummins, M.; Murone, C.; Tebbutt, N.
2011Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsKantarjian, H.; Giles, F.; Bhalla, K.; Pinilla-Ibarz, J.; Larson, R.; Gattermann, N.; Ottmann, O.; Hochhaus, A.; Radich, J.; Saglio, G.; Hughes, T.; Martinelli, G.; Kim, D.; Shou, Y.; Gallagher, N.; Blakesley, R.; Baccarani, M.; Cortes, J.; le Coutre, P.
2011Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b studyKotasek, D.; Tebbutt, N.; Desai, J.; Welch, S.; Siu, L.; McCoy, S.; Sun, Y.; Johnson, J.; Adewoye, A.; Price, T.
2011Phase 2 trial of romidepsin in patients with peripheral T-cell lymphomaPiekarz, R.; Frye, R.; Prince, H.; Kirschbaum, M.; Zain, J.; Allen, S.; Jaffe, E.; Ling, A.; Turner, M.; Peer, C.; Figg, W.; Steinberg, S.; Smith, S.; Joske, D.; Lewis, I.; Hutchins, L.; Craig, M.; Fojo, A.; Wright, J.; Bates, S.

Discover